Healthy volunteers needed to test two versions of cholesterol drug
NCT ID NCT07545226
First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 4 times
Summary
This study tests two different forms of the drug evolocumab in 400 healthy adults aged 18 to 60. The goal is to see how the body processes each version and to check for side effects. Participants receive a single dose and are monitored for about two months. This is not a treatment study—it helps researchers understand the drug better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anaheim Clinical Trials
Anaheim, California, 92801-2658, United States
-
Fortrea Clinical Research Unit - Dallas
Dallas, Texas, 75247, United States
-
QPS Bio-Kinetic
Springfield, Missouri, 65802, United States
-
Quest Pharmaceutical Services - Miami Research Associates - Early Phase
South Miami, Florida, 33143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates